Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding
Not Applicable
Completed
- Conditions
- Active Peptic Ulcer Disease/GI Bleeding
- Interventions
- Device: epinephrine injection plus argon plasma coagulationDevice: epinephrine injection plus soft coagulation using hemostatic forceps
- Registration Number
- NCT02020603
- Lead Sponsor
- Kyunghee University Medical Center
- Brief Summary
Endoscopic high-frequency soft coagulation is available for the management of bleeding or nonbleeding visible vessels during endoscopic submucosal dissection. However, its efficacy on peptic ulcer bleeding has not been elucidated so far. The aim of this study was to evaluate the efficacy of hemostasis with soft coagulation using hemostatic forceps by comparing it with argon plasma coagulation (APC) in a prospective, randomized trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 151
Inclusion Criteria
- age greater than 18 years
- peptic ulcer with stigmata of recent hemorrhage
Exclusion Criteria
- malignant ulcer
- previous gastric surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description APC group epinephrine injection plus argon plasma coagulation epinephrine injection plus argon plasma coagulation Forceps group epinephrine injection plus soft coagulation using hemostatic forceps epinephrine injection plus soft coagulation using hemostatic forceps
- Primary Outcome Measures
Name Time Method Recurrence of bleeding within four weeks after initial hemostasis up to 24 months
- Secondary Outcome Measures
Name Time Method initial hemostasis rate up to 24 months
Trial Locations
- Locations (1)
Kyung Hee University Hospital
🇰🇷Seoul, Korea, Republic of